Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety, Tolerability, and Pharmacokinetics After Multiple Doses of Orally Inhaled DNAzyme Solution for Nebulisation in Healthy Male Subjects

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Sterna Biologicals GmbH & Co. KG
ClinicalTrials.gov Identifier:
NCT01554319
First received: March 8, 2012
Last updated: November 22, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2012
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)